Synageva BioPharma Presents Sebelipase Alfa Data At The NASPGHAN Meeting
October 23, 2014 at 16:18 PM EDT
Synageva BioPharma Corp. (Synageva) (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, ...
